PGK ARF6(Q67L)-CFP
(Plasmid
#200428)
-
PurposeMammalian expression of Q67L mutation in ARF6
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 200428 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepECFP-N1/PGK
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 3900
- Total vector size (bp) 5200
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameARF6
-
Alt nameADP ribosylation factor 6
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1300
-
MutationQ67L
-
GenBank IDNP_001654
-
Entrez GeneARF6
- Promoter PGK
-
Tag
/ Fusion Protein
- CFP (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (unknown if destroyed)
- 3′ cloning site NarI (unknown if destroyed)
- 5′ sequencing primer 5'-TGGGGTTGCGCCTTTTCC
- 3′ sequencing primer 5'-CTTTATTTGTAACCATTATAAGCTGC (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAddgene #11387
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
PGK ARF6(Q67L)-CFP was a gift from Erika Holzbaur (Addgene plasmid # 200428 ; http://n2t.net/addgene:200428 ; RRID:Addgene_200428) -
For your References section:
Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomes. Dou D, Smith EM, Evans CS, Boecker CA, Holzbaur ELF. Cell Rep. 2023 May 1;42(5):112448. doi: 10.1016/j.celrep.2023.112448. 10.1016/j.celrep.2023.112448 PubMed 37133994